The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the second thing we do is we're very liberal in the use of pcsk9 inhibitors because even though we don't know the answer yet our belief is even if it whacks it 30 which is about what we see we see on average about a 30 reduction in lp little a it's worth it until we get to antisense oligonucleotides
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the second thing we do is we're very liberal in the use of pcsk9 inhibitors because even though we don't know the answer yet our belief is even if it whacks it 30 which is about what we see we see on average about a 30 reduction lp little a it's worth it until we get to antisense oligonucleotides
I also use them in high risk primer prevention such as those with high calcium scores who need LDL lowering